Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.52 |
| ▸ | APP | P05067 | 1/20 | 0.48 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.46 |
| ▸ | GRM5 | P41594 | 10/20 | 0.45 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4736199 | 0.82 | FFAR1 (0.44) | FFAR1TRPA1ASIC3GRM5KCNH2 | |
| SCHEMBL2529804 | 0.81 | GRM5 (0.57) | FFAR1TRPA1GRM5KCNH2 | |
| SCHEMBL7958115 | 0.78 | FFAR1 (0.45) | FFAR1TRPA1GRM5KCNH2TDP1 | |
| SCHEMBL9947880 | 0.78 | FFAR1 (0.46) | FFAR1TRPA1GRM5KCNH2TDP1 | |
| SCHEMBL4734297 | 0.77 | FFAR1 (0.50) | FFAR1APPGRM5KCNH2 | |
| SCHEMBL23918702 | 0.76 | FFAR1 (0.56) | FFAR1APPASIC3GRM5GRM4 | |
| SCHEMBL3498257 | 0.76 | ASIC3 (0.54) | APPASIC3GRM5GRM4 | |
| SCHEMBL16139763 | 0.76 | GRM5 (0.57) | FFAR1APPASIC3GRM5GRM4 | |
| SCHEMBL39723 | 0.74 | FFAR1 (0.44) | FFAR1TRPA1GRM5KCNH2 | |
| SCHEMBL13388214 | 0.74 | FFAR1 (0.55) | FFAR1GRM5KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012084678-A1 | NOVEL IMIDAZOLES USEFUL AS PLANT FUNGICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2012-06-28 | — | — | WO | disclosed |
| US-20100130737-A1 | Regulating Agent of GPR34 Receptor Function | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-05-27 | — | — | US | disclosed |
| EP-1849465-A1 | AGENT FOR CONTROLLING FUNCTION OF GPR34 RECEPTOR | Takeda Pharmaceutical Company Limited (JP) | 2007-10-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130737-A1 | Regulating Agent of GPR34 Receptor Function | GPR34, GPR4, GPR6 | FFAR1 33/4885TRPA1 337/4885APP 2850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.